Nutex Health is trading at $187.31, down 5.16%, with no new company-specific announcement identified for August 11, 2026.

  • The decline follows a 21.87% gain on August 10, suggesting profit-taking, though this is not directly confirmed.
  • Recent earnings showed strong EPS but a 13.6% year-over-year revenue decline, adding volatility.